Scinai Immunotherapeutics Ltd. SEC filings SCNI
Scinai Immunotherapeutics Ltd. has 495 filings in SEC EDGAR's recent list, going back to Nov 13, 2014. Its latest annual report, Form 20-F, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on May 15, 2023, covering the quarter ended Mar 31, 2023. The most recent current report (Form 6-K) was filed on Oct 20, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 9, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 1, 2026 | — |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 3 | Initial insider ownership | Mar 26, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 1, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 26, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 4, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 24, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 24, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 3, 2025 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Aug 20, 2024 | — |
| SC 13D | Ownership over 5% (active) | Mar 12, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 24, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 2, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 6, 2023 | — |
| 3/A | Filing | Jan 23, 2023 | Jan 1, 2023 |
| 3/A | Filing | Jan 23, 2023 | Jan 1, 2023 |
| 3/A | Filing | Jan 23, 2023 | Jan 1, 2023 |
| 3/A | Filing | Jan 23, 2023 | Jan 1, 2023 |
| 3 | Initial insider ownership | Jan 5, 2023 | Jan 1, 2023 |
| SC 13G | Ownership over 5% (passive) | Jan 4, 2023 | — |
| 3 | Initial insider ownership | Jan 3, 2023 | Jan 1, 2023 |
| 3 | Initial insider ownership | Jan 3, 2023 | Jan 1, 2023 |
| 3 | Initial insider ownership | Jan 3, 2023 | Jan 1, 2023 |
| 3 | Initial insider ownership | Jan 3, 2023 | Jan 1, 2023 |
| 3 | Initial insider ownership | Jan 3, 2023 | Jan 1, 2023 |
| 3 | Initial insider ownership | Jan 3, 2023 | Jan 1, 2023 |
| 3 | Initial insider ownership | Jan 3, 2023 | Jan 1, 2023 |
| 3 | Initial insider ownership | Jan 3, 2023 | Jan 1, 2023 |
| 3 | Initial insider ownership | Jan 3, 2023 | Jan 1, 2023 |
| 3 | Initial insider ownership | Jan 3, 2023 | Jan 1, 2023 |
| 3 | Initial insider ownership | Jan 3, 2023 | Jan 1, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Dec 27, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Oct 6, 2022 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jan 11, 2022 | — |
| SC 13D/A | Amended ownership over 5% (active) | Feb 9, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 24, 2020 | — |
| SC 13D/A | Amended ownership over 5% (active) | Nov 12, 2019 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 28, 2019 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 2, 2018 | — |
| SC 13D/A | Amended ownership over 5% (active) | Sep 27, 2017 | — |
| SC 13G | Ownership over 5% (passive) | Sep 26, 2017 | — |
| SC 13G | Ownership over 5% (passive) | Sep 22, 2017 | — |
| SC 13D | Ownership over 5% (active) | Feb 16, 2017 | — |
| SC 13G | Ownership over 5% (passive) | Feb 16, 2016 | — |
Showing 56 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- SCNI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Jerusalem, Israel
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1611747
- Former names
- BiondVax Pharmaceuticals Ltd. (until Aug 28, 2023)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.